← Back to Search

Behavioural Intervention

Sleep and Circadian Rhythm Study for High Blood Pressure (SCN-BP Trial)

N/A
Waitlist Available
Led By Stephen J Thomas, PhD
Research Sponsored by University of Alabama at Birmingham
Eligibility Criteria Checklist
Specific guidelines that determine who can or cannot participate in a clinical trial
Must have
Participant in the parent grant (IDH-MEGA)
Be older than 18 years old
Timeline
Screening 3 weeks
Treatment Varies
Follow Up measurements obtained every 30 minutes over 30 hours
Awards & highlights

SCN-BP Trial Summary

This trial looks at how sleep and body clock affect nighttime blood pressure.

Who is the study for?
This trial is for participants of the parent grant IDH-MEGA who are interested in understanding how sleep and their body's internal clock affect nighttime blood pressure.Check my eligibility
What is being tested?
The study is exploring how sleep patterns and circadian rhythms influence high blood pressure at night using a Constant Routine Protocol to monitor changes.See study design
What are the potential side effects?
Since this trial involves monitoring rather than medication, side effects are minimal but may include discomfort from wearing monitoring equipment or disruption of normal sleep patterns.

SCN-BP Trial Eligibility Criteria

Inclusion Criteria

You may be eligible if you check “Yes” for the criteria below

SCN-BP Trial Timeline

Screening ~ 3 weeks
Treatment ~ Varies
Follow Up ~measurements obtained every 30 minutes over 30 hours
This trial's timeline: 3 weeks for screening, Varies for treatment, and measurements obtained every 30 minutes over 30 hours for reporting.

Treatment Details

Study Objectives

Outcome measures can provide a clearer picture of what you can expect from a treatment.
Primary outcome measures
Change in Core body temperature
Change in Melatonin
Secondary outcome measures
Change in Blood pressure

SCN-BP Trial Design

1Treatment groups
Experimental Treatment
Group I: Constant Routine ProtocolExperimental Treatment1 Intervention
Participants complete a 30-hour constant routine protocol to directly examine markers of endogenous circadian rhythms. In a constant routine protocol, participants remain in a dimly lit room (<10 lux), in a semi-recumbent posture, remain awake, and consume iso-caloric snacks. Saliva samples are collected and core body temperature and blood pressure are measured.

Find a Location

Who is running the clinical trial?

University of Alabama at BirminghamLead Sponsor
1,581 Previous Clinical Trials
2,277,959 Total Patients Enrolled
1 Trials studying Sleep
87 Patients Enrolled for Sleep
Stephen J Thomas, PhDPrincipal InvestigatorUniversity of Alabama at Birmingham

Media Library

Constant Routine Protocol (Behavioural Intervention) Clinical Trial Eligibility Overview. Trial Name: NCT05656768 — N/A
Sleep Research Study Groups: Constant Routine Protocol
Sleep Clinical Trial 2023: Constant Routine Protocol Highlights & Side Effects. Trial Name: NCT05656768 — N/A
Constant Routine Protocol (Behavioural Intervention) 2023 Treatment Timeline for Medical Study. Trial Name: NCT05656768 — N/A

Frequently Asked Questions

These questions and answers are submitted by anonymous patients, and have not been verified by our internal team.

Is enrollment for this research study currently open?

"As per the details on clinicaltrials.gov, this particular medical experiment is not presently acquiring applicants. It was initially announced on June 1st 2023 and edited most recently on June 22nd 2023. Despite that no individuals are being sought for this trial at present time, there are 952 other studies seeking participants right now."

Answered by AI
~47 spots leftby Dec 2028